The results demonstrated significantly higher expression levels of LAPTM5, SLC40A1, TYROBP, CTSB, and PYCARD in the serum of atherosclerosis patients compared to the healthy controls (Figure 8a,b). Here, SLC40A1 is linked to atherosclerosis.